|A/Prof Jeremy Grummet with a colleague. He is an advocate for|
non-invasive diagnostic techniques for prostate cancer
- Date: Thursday 26 April 2018
- Time: 5.30pm refreshments for 6.00pm start. Lecture will be followed by Q&A session
- Venue: AMREP Lecture Theatre
- Cost: Free
- RSVP: link
- Enquiries: E email@example.com T +61 3 9903 0611
The entire controversy surrounding prostate cancer and whether we should test for it arises from how we diagnose it. Even today, clinical guidelines tell us that if a man has an elevated PSA test (Prostate-Specific Antigen), the next step is to perform a random tissue sampling of the prostate gland by passing biopsy needles through the rectum. We know that this process subjects men to an unnecessary, invasive, even dangerous, procedure about half the time.
But in Australia, we’ve been early adopters of prostate MRI, a highly accurate non-invasive test which helps us avoid unnecessary biopsies when negative and allow a targeted biopsy when it does show a suspicious lesion. And that’s just the start of our revolution. We also routinely perform biopsy through the skin instead of the rectum, virtually eliminating the risk of serious infection of transrectal biopsy. And we’ve been at the forefront of another superb imaging modality – PSMA PET – a highly sensitive test for detecting spread of prostate cancer.
Associate Professor Jeremy Grummet MBBS, MS, FRACS
A/Prof Jeremy Grummet is a consultant urologist and Director of Clinical Research of the Urology Unit at Alfred Health, overseeing multiple currently recruiting clinical trials. He is also supervisor to past and present Monash University Master of Surgery and Bachelor of Medical Science students in prostate cancer diagnostics, including prostate MRI, PSMA PET scanning and optimal prostate biopsy techniques.
A/Prof Grummet has conducted practice-changing research and published widely on performing prostate biopsy via the skin instead of the rectum, reducing the infection risk to near-zero. His papers have been cited in the US National Comprehensive Cancer Network Guidelines and awarded the British Journal of Urology International’s Global Prize.
In addition to his clinical and research work, A/Prof Grummet is currently producing a global online educational platform enabling specialists to become experts in reporting prostate MRI, due for launch this year.
Follow Jeremy at: @JGrummet